Dr. Phong H. Bui, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Medical school
- University of California, Irvine, California College of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2009
- Medicare patients seen, 2024
- 881
Licensed in California since 2007, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2006Medical school: University of California, Irvine, California College of Medicine
- 2009Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CA license A101682 (first issued 2007; current) -
Internal Medicine Physician
CA license A101682 (first issued 2007; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Uci Health-Orange Orange, CA
Medical groups
- Family Choice Aco Inc (55 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 881
- Services billed
- 3,577
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 1,419 | 719 |
| Blood glucose (sugar) test performed by hand-held instrument | 823 | 447 |
| Blood glucose (sugar) level | 260 | 233 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 252 | 103 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 244 | 105 |
| Established patient office or other outpatient visit, 40-54 minutes | 165 | 77 |
| New patient office or other outpatient visit, 45-59 minutes | 139 | 139 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 61 | 47 |
| Injection of drug or substance under skin or into muscle | 26 | 15 |
| Established patient office or other outpatient visit, 20-29 minutes | 12 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Ozempic (semaglutide) Other prescribers in Fountain Valley, CA | 1,314 |
| Synjardy Xr (empagliflozin/metformin hcl) Other prescribers in Fountain Valley, CA | 1,141 |
| Jardiance (empagliflozin) Other prescribers in Fountain Valley, CA | 975 |
| Pioglitazone Hcl Other prescribers in Fountain Valley, CA | 820 |
| Trulicity (dulaglutide) Other prescribers in Fountain Valley, CA | 808 |
| Metformin Hcl Other prescribers in Fountain Valley, CA | 739 |
| Levothyroxine Sodium Other prescribers in Fountain Valley, CA | 700 |
| Ultra-Fine Nano Pen Needle (pen needle, diabetic) Other prescribers in Fountain Valley, CA | 472 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Fountain Valley, CA | 455 |
| Rybelsus (semaglutide) Other prescribers in Fountain Valley, CA | 431 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 77 payments worth $1,617 in total to this clinician.
| Novo Nordisk Inc | $310 |
|---|---|
| Amgen Inc. | $221 |
| Lilly USA, LLC | $209 |
| Corcept Therapeutics | $198 |
| Mannkind Corporation | $161 |
| Abbott Laboratories | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $90.43 |
| Dexcom, Inc. | $78.92 |
| Food and Beverage | $1,575 |
|---|---|
| Education | $42.50 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Mannkind Corporation Mar 8, 2025 | Education AFREZZA · DIABETES MEDICINE · in-kind | $42.50 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.